August 3 (SeeNews) - The offers submitted by all three bidders in the tender for the purchase of a 25% stake in Serbia’s indebted state-controlled drug maker Galenika contain certain technical flaws, the country's economy ministry said, giving the potential investors two weeks to make corrections.